Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
NjmHemcaSMvDrePU